FDA Circulatory Systems Devices Panel to hold a meeting The Panel discusses, makes recommendations and votes on information related to C.R. Bard's Premarket Approval Application for the LUTONIX 035 Drug Coated Balloon PTA Catheter in a meeting being held in Germantown, Maryland on June 12 at 8 am. Webcast Link
C.R. Bard upgraded to Neutral from Underweight at JPMorgan JPMorgan upgraded C.R. Bard to Neutral on expectations drug-coated balloons growth in the U.S. is likely to exceed consensus expectations. The firm raised its price target for shares to $178 from $162.